Methods We performed an echocardiographic prevalence study in 155 patients taking dopamine agonists for Parkinson's disease (pergolide, 64 patients; cabergoline, 49; and non–ergot-derived dopamine agonists, 42) and 90 control subjects.
Methods We performed an echocardiographic prevalence study in 155 patients taking dopamine agonists for Parkinson's disease (pergolide, 64 patients; cabergoline, 49; and non–ergot-derived dopamine agonists, 42) and 90 control subjects.
方法：我们用超声心动图对155例正在服用多巴胺受体激动剂（64例服用培高利特，49例服用卡麦角林，42例服用非麦角洐生的多巴胺受体激动剂）治疗帕金森病的患者和90例对照组进行了一项流行调查。